Initial therapeutic dose of corticosteroid for an acute exacerbation of IPF is associated with subsequent early recurrence of another exacerbation
Abstract Some patients with idiopathic pulmonary fibrosis (IPF) undergo recurrent acute exacerbations (AEs). This study aimed to elucidate the risk factors for recurrent AEs of IPF (AE-IPF). Consecutive patients with IPF admitted for their first AE-IPF between January 2008 and December 2018 were ret...
Guardado en:
Autores principales: | Ryo Yamazaki, Osamu Nishiyama, Sho Saeki, Hiroyuki Sano, Takashi Iwanaga, Yuji Tohda |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/efa573444f064c61afdfcc6679e85883 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Comparison of CURB-65, PSI, and qSOFA for predicting pneumonia mortality in patients with idiopathic pulmonary fibrosis
por: Ryo Yamazaki, et al.
Publicado: (2021) -
Correlates of survival after autoantibody reduction therapy for acute IPF exacerbations.
por: Tejaswini Kulkarni, et al.
Publicado: (2021) -
Delayed HIV diagnosis in a cystic fibrosis patient: Not just another exacerbation
por: Sapna Bhatia, et al.
Publicado: (2021) -
Corticosteroid suppression of antiviral immunity increases bacterial loads and mucus production in COPD exacerbations
por: Aran Singanayagam, et al.
Publicado: (2018) -
Corticosteroid responsiveness in patients with acute exacerbation of interstitial lung disease admitted to the emergency department
por: Hye Jin Jang, et al.
Publicado: (2021)